Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 19 | 2020 | 3736 | 1.440 |
Why?
|
| Delirium | 9 | 2018 | 1663 | 1.210 |
Why?
|
| Sleep Deprivation | 6 | 2020 | 840 | 1.200 |
Why?
|
| Critical Care | 11 | 2019 | 2699 | 0.990 |
Why?
|
| Epoprostenol | 2 | 2015 | 248 | 0.880 |
Why?
|
| Critical Illness | 11 | 2020 | 2709 | 0.870 |
Why?
|
| Tranexamic Acid | 1 | 2023 | 176 | 0.740 |
Why?
|
| Antifibrinolytic Agents | 2 | 2023 | 292 | 0.730 |
Why?
|
| Ear Protective Devices | 1 | 2016 | 10 | 0.540 |
Why?
|
| Analgesics | 2 | 2016 | 1065 | 0.530 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2016 | 130 | 0.500 |
Why?
|
| Hypnotics and Sedatives | 2 | 2016 | 1178 | 0.500 |
Why?
|
| Respiratory Insufficiency | 2 | 2015 | 1231 | 0.490 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2017 | 1459 | 0.420 |
Why?
|
| Respiratory Muscles | 1 | 2013 | 142 | 0.420 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 749 | 0.420 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.400 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2015 | 277 | 0.380 |
Why?
|
| Checklist | 1 | 2018 | 827 | 0.370 |
Why?
|
| Administration, Inhalation | 3 | 2023 | 1156 | 0.370 |
Why?
|
| Deep Sedation | 4 | 2018 | 118 | 0.360 |
Why?
|
| Respiration Disorders | 1 | 2013 | 368 | 0.340 |
Why?
|
| Tetrazoles | 1 | 2015 | 905 | 0.340 |
Why?
|
| Bronchodilator Agents | 1 | 2013 | 506 | 0.340 |
Why?
|
| Psychomotor Agitation | 4 | 2018 | 305 | 0.330 |
Why?
|
| Benzhydryl Compounds | 1 | 2015 | 941 | 0.300 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 556 | 0.300 |
Why?
|
| Fatigue | 1 | 2015 | 1544 | 0.290 |
Why?
|
| Tracheostomy | 1 | 2011 | 425 | 0.290 |
Why?
|
| Conscious Sedation | 4 | 2018 | 529 | 0.280 |
Why?
|
| Radiography | 1 | 2018 | 6965 | 0.280 |
Why?
|
| Quality Improvement | 2 | 2019 | 3836 | 0.270 |
Why?
|
| Sleep | 4 | 2023 | 4751 | 0.260 |
Why?
|
| Restraint, Physical | 4 | 2018 | 186 | 0.240 |
Why?
|
| Survivors | 4 | 2019 | 2375 | 0.240 |
Why?
|
| Sleep Stages | 1 | 2008 | 691 | 0.230 |
Why?
|
| Nitric Oxide | 1 | 2013 | 2141 | 0.230 |
Why?
|
| Peer Group | 3 | 2019 | 674 | 0.230 |
Why?
|
| Pyridines | 1 | 2015 | 2879 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 1 | 2015 | 1913 | 0.220 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 2061 | 0.220 |
Why?
|
| Hemoptysis | 1 | 2023 | 152 | 0.200 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2014 | 213 | 0.200 |
Why?
|
| Propofol | 2 | 2017 | 608 | 0.180 |
Why?
|
| Lung Diseases | 3 | 2021 | 1915 | 0.160 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2018 | 20 | 0.150 |
Why?
|
| Self-Help Groups | 1 | 2019 | 189 | 0.150 |
Why?
|
| Social Support | 2 | 2019 | 2145 | 0.150 |
Why?
|
| Oxygenators | 1 | 2017 | 36 | 0.140 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2019 | 389 | 0.140 |
Why?
|
| Respiration, Artificial | 3 | 2015 | 2622 | 0.140 |
Why?
|
| Subacute Care | 1 | 2019 | 177 | 0.140 |
Why?
|
| Humans | 40 | 2023 | 760621 | 0.130 |
Why?
|
| Positive-Pressure Respiration | 2 | 2010 | 636 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2014 | 15697 | 0.120 |
Why?
|
| Midazolam | 1 | 2016 | 267 | 0.120 |
Why?
|
| Noise | 1 | 2016 | 280 | 0.110 |
Why?
|
| Bronchi | 2 | 2019 | 848 | 0.110 |
Why?
|
| Biomedical Research | 3 | 2018 | 3426 | 0.110 |
Why?
|
| Pain | 2 | 2018 | 5066 | 0.110 |
Why?
|
| Fentanyl | 1 | 2016 | 434 | 0.110 |
Why?
|
| Busulfan | 1 | 2014 | 258 | 0.110 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1993 | 285 | 0.100 |
Why?
|
| APACHE | 1 | 2013 | 267 | 0.100 |
Why?
|
| Standard of Care | 2 | 2019 | 552 | 0.100 |
Why?
|
| Male | 20 | 2023 | 359744 | 0.100 |
Why?
|
| Length of Stay | 2 | 2016 | 6479 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2016 | 316 | 0.100 |
Why?
|
| Female | 20 | 2023 | 391270 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 1066 | 0.100 |
Why?
|
| Adult | 18 | 2023 | 219994 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 978 | 0.090 |
Why?
|
| Middle Aged | 18 | 2019 | 220352 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2023 | 3905 | 0.090 |
Why?
|
| Manometry | 1 | 2013 | 453 | 0.090 |
Why?
|
| Aged | 10 | 2023 | 169152 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2016 | 1131 | 0.090 |
Why?
|
| Patients | 1 | 2016 | 906 | 0.080 |
Why?
|
| Shock, Cardiogenic | 1 | 2015 | 734 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 2011 | 275 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2014 | 5649 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2018 | 1305 | 0.080 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 1683 | 0.080 |
Why?
|
| Electromyography | 1 | 2013 | 1388 | 0.080 |
Why?
|
| Syndrome | 2 | 2016 | 3280 | 0.080 |
Why?
|
| High-Frequency Ventilation | 1 | 1988 | 88 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2283 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2023 | 80372 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2013 | 2221 | 0.070 |
Why?
|
| Esophagus | 1 | 2013 | 1023 | 0.070 |
Why?
|
| Transplantation Conditioning | 1 | 2014 | 1588 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3448 | 0.070 |
Why?
|
| Bronchoscopy | 2 | 2019 | 911 | 0.070 |
Why?
|
| Speech | 1 | 2011 | 550 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5508 | 0.070 |
Why?
|
| Glycoproteins | 1 | 1993 | 2208 | 0.060 |
Why?
|
| Restless Legs Syndrome | 1 | 2008 | 233 | 0.060 |
Why?
|
| Catecholamines | 1 | 2006 | 385 | 0.060 |
Why?
|
| Dyspnea | 1 | 2013 | 1352 | 0.060 |
Why?
|
| Oxygen | 3 | 2010 | 4193 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3202 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 1993 | 4433 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 1843 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2016 | 3600 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2571 | 0.050 |
Why?
|
| Sleep, REM | 1 | 2006 | 593 | 0.050 |
Why?
|
| Polysomnography | 2 | 2023 | 1825 | 0.050 |
Why?
|
| Hormones | 1 | 2006 | 867 | 0.050 |
Why?
|
| Comorbidity | 2 | 2014 | 10551 | 0.050 |
Why?
|
| Thrombosis | 1 | 2016 | 3052 | 0.050 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 3025 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7475 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2023 | 41335 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2016 | 4446 | 0.040 |
Why?
|
| Vital Capacity | 2 | 2014 | 965 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 3763 | 0.040 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 974 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2019 | 2963 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 2014 | 1809 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2015 | 65017 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 2693 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 54303 | 0.030 |
Why?
|
| Disease Progression | 1 | 2013 | 13502 | 0.030 |
Why?
|
| Feedback | 1 | 2019 | 791 | 0.030 |
Why?
|
| Models, Economic | 1 | 2019 | 719 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13262 | 0.030 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 506 | 0.030 |
Why?
|
| Risk Factors | 4 | 2020 | 74359 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 40165 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2016 | 418 | 0.030 |
Why?
|
| Cost Savings | 1 | 2019 | 920 | 0.030 |
Why?
|
| Bronchography | 1 | 2012 | 76 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 1724 | 0.030 |
Why?
|
| Antilymphocyte Serum | 1 | 2014 | 482 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1392 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2659 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2012 | 134 | 0.020 |
Why?
|
| Actigraphy | 1 | 2015 | 518 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2012 | 527 | 0.020 |
Why?
|
| Cattle | 2 | 1993 | 3847 | 0.020 |
Why?
|
| Surface Properties | 1 | 1993 | 1161 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1993 | 795 | 0.020 |
Why?
|
| Family | 1 | 2019 | 3189 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6771 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2651 | 0.020 |
Why?
|
| Hospitalization | 1 | 2006 | 10790 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36290 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6218 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2019 | 3476 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2014 | 22053 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8035 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3865 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 2628 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2010 | 2648 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1988 | 1146 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14660 | 0.010 |
Why?
|
| Young Adult | 3 | 2016 | 58741 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1988 | 2502 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9411 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20509 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5397 | 0.010 |
Why?
|
| United States | 2 | 2023 | 72461 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4166 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12159 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58995 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39261 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15687 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10181 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15289 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1993 | 658 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 5425 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1993 | 1955 | 0.000 |
Why?
|
| Animals | 2 | 1993 | 167963 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1993 | 18957 | 0.000 |
Why?
|
| Rats | 1 | 1993 | 23711 | 0.000 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_